Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Non-Current Deferred Tax Liability (2023 - 2025)

Historic Non-Current Deferred Tax Liability for Barinthus Biotherapeutics (BRNS) over the last 3 years, with Q3 2025 value amounting to $320000.0.

  • Barinthus Biotherapeutics' Non-Current Deferred Tax Liability fell 2997.81% to $320000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $320000.0, marking a year-over-year decrease of 2997.81%. This contributed to the annual value of $438000.0 for FY2024, which is 9627.23% down from last year.
  • As of Q3 2025, Barinthus Biotherapeutics' Non-Current Deferred Tax Liability stood at $320000.0, which was down 2997.81% from $391000.0 recorded in Q2 2025.
  • In the past 5 years, Barinthus Biotherapeutics' Non-Current Deferred Tax Liability ranged from a high of $11.8 million in Q4 2023 and a low of $320000.0 during Q3 2025
  • For the 3-year period, Barinthus Biotherapeutics' Non-Current Deferred Tax Liability averaged around $2.3 million, with its median value being $427000.0 (2024).
  • In the last 5 years, Barinthus Biotherapeutics' Non-Current Deferred Tax Liability tumbled by 9627.23% in 2024 and then tumbled by 2997.81% in 2025.
  • Barinthus Biotherapeutics' Non-Current Deferred Tax Liability (Quarter) stood at $11.8 million in 2023, then crashed by 96.27% to $438000.0 in 2024, then fell by 26.94% to $320000.0 in 2025.
  • Its last three reported values are $320000.0 in Q3 2025, $391000.0 for Q2 2025, and $416000.0 during Q1 2025.